Literature DB >> 17516211

HMGB1: a signal of necrosis.

Angela Raucci1, Roberta Palumbo, Marco E Bianchi.   

Abstract

When tissues are damaged, they usually heal. The cellular responses towards healing require the prior recognition that damage has occurred. High Mobility Group Box 1 protein (HMGB1) is a ubiquitous nuclear protein that is passively released by cells that have died in a traumatic, non-programmed way (necrosis). Several receptors for HMGB1 exist, and upon binding HMGB1 they alert leukocytes to extravasate from the blood into the affected tissue, trigger adaptive immunity and promote the migration and proliferation of cells (including stem cells) to repair the damaged tissue. Significantly, apoptotic cells modify their chromatin so as to bind HMGB1, which is not released. Several cell types (in particular inflammatory cells) when distressed have the ability to secrete HMGB1 actively, via a dedicated pathway, and thus produce a damage signal without dying. Because of its powerful activities, HMGB1 is involved in several disorders, including autoimmune ones.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516211     DOI: 10.1080/08916930701356978

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  65 in total

1.  Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1.

Authors:  Roberto Romero; Tinnakorn Chaiworapongsa; Zeynep Alpay Savasan; Yi Xu; Youssef Hussein; Zhong Dong; Juan Pedro Kusanovic; Chong Jai Kim; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2011-09-29

2.  Calcium electroporation induces tumor eradication, long-lasting immunity and cytokine responses in the CT26 colon cancer mouse model.

Authors:  Hanne Falk; Patrick F Forde; Marie Lund Bay; Uma Maheswari Mangalanathan; Pernille Hojman; Declan M Soden; Julie Gehl
Journal:  Oncoimmunology       Date:  2017-03-17       Impact factor: 8.110

3.  Dear SIRS, the concept of "alarmins" makes a lot of sense!

Authors:  Jérôme Pugin
Journal:  Intensive Care Med       Date:  2007-10-17       Impact factor: 17.440

Review 4.  Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.

Authors:  Geetha Srikrishna; Hudson H Freeze
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

5.  Effect of different 1, 25-(OH)2D3 doses on high mobility group box1 and toll-like receptors 4 expression in lung tissue of asthmatic mice.

Authors:  Junying Qiao; Bin Luan; Huiru Gu; Yanli Zhang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  YAP plays a crucial role in the development of cardiomyopathy in lysosomal storage diseases.

Authors:  Shohei Ikeda; Jihoon Nah; Akihiro Shirakabe; Peiyong Zhai; Shin-Ichi Oka; Sebastiano Sciarretta; Kun-Liang Guan; Hiroaki Shimokawa; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

7.  Liuweiwuling tablets attenuate acetaminophen-induced acute liver injury and promote liver regeneration in mice.

Authors:  Yan-Chang Lei; Wen Li; Pan Luo
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

8.  Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells.

Authors:  Jana N Radin; Christian González-Rivera; Susan E Ivie; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2011-04-11       Impact factor: 3.441

Review 9.  Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells.

Authors:  Chang-Qing Xia; Kim A Campbell; Michael J Clare-Salzler
Journal:  Curr Opin Organ Transplant       Date:  2009-08       Impact factor: 2.640

10.  Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells.

Authors:  Sebastian Vogel; Thorsten Trapp; Verena Börger; Corinna Peters; Dalila Lakbir; Dagmar Dilloo; Rüdiger V Sorg
Journal:  Cell Mol Life Sci       Date:  2009-11-03       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.